Hepatitis C virus infection among patients on hemodialysis a report from a single center in Iran

Abstract EN

The aim of this study is to evaluate the incidence of hepatitis C virus (HCV) infection among the hemodialysis (HD) patients at the Nephrology and Urology Research Center, Tehran, Iran, and identify the potential risk factors.

A total of 112 patients on HD in our two dialysis units were studied.

The mean duration of follow-up was 27 ± 27 months (range, 6-132).

All study subjects were HCV-negative at entry to the study and were tested for anti-HCV antibody by ELISA II every six months thereafter.

Positive samples were re-examined by RT / PCR for confirmation.

Factors that might be implicated in HCV transmission were evaluated.

Six patients (5.3%) were labeled as HCV infected, at the end of the follow-up period.

Thus, the incidence of HCV infection in our dialysis units was 1.8 per 100 person years.

A total of 64.5% of the study population had previous history of blood transfusion(s) and 8% had undergone prior transplantation.

Univariate analysis showed a significant relationship between number of blood transfusions and duration on dialysis and HCV infection.

Multivariate analysis revealed that only duration on HD was significantly associated with HCV positivity (OR: 1.03, p = 0.008).

Our study further suggests that nosocomial transmission plays a major role in HCV transmission among patients on HD.

Meticulous practice of preventive measures is essential to eradicate the spread of HCV in HD units.